(Q51539526)

6 April 2018

title

A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. (English)

1 reference

6 April 2018

1 reference

2

1 reference

6 April 2018

author name string

Halikas JA

series ordinal

1

1 reference

6 April 2018

Pearson VL

series ordinal

3

1 reference

6 April 2018

Graves NM

series ordinal

4

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 July 1997

1 reference

6 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

6 April 2018

volume

62

1 reference

6 April 2018

issue

1

1 reference

6 April 2018

page(s)

89-105

1 reference

6 April 2018

Achieving cocaine abstinence with a behavioral approach.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Cocaine, kindling, and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Drugs 5 years later: carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

The Effect of Carbamazepine on Cocaine Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Psychological Approaches for the Treatment of Cocaine Dependence-A Neurobehavioral Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Crack cocaine: what constitutes state of the art treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Interpersonal psychotherapy adapted for ambulatory cocaine abusers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Current pharmacotherapies for cocaine abuse: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

New concepts in cocaine addiction: the dopamine depletion hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

The neural basis of drug craving: an incentive-sensitization theory of addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

A permanent change in brain function resulting from daily electrical stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Carbamazepine for cocaine addiction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Treatment of crack cocaine use with carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Reduction of Cocaine Use Among Methadone Maintenance Patients Using Concurrent Carbamazepine Maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Measuring outcome in the treatment of cocaine abuse: the Drug Impairment Rating Scale for cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Random-effects models for serial observations with binary response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Carbamazepine treatment for cocaine dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Carbamazepine (Tegretol) drug eruptions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Suppression of carbamazepine-induced rash with prednisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Carbamazepine and hematological monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Carbamazepine treatment of cocaine dependence: a placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990155-7

10.1016/S0009-9236(97)90155-7

7 January 2021

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

9246023

1 reference

6 April 2018